ID28213A - Metode dan komposisi transdermal untuk meredakan rasa sakit - Google Patents

Metode dan komposisi transdermal untuk meredakan rasa sakit

Info

Publication number
ID28213A
ID28213A IDW20010231A ID20010231A ID28213A ID 28213 A ID28213 A ID 28213A ID W20010231 A IDW20010231 A ID W20010231A ID 20010231 A ID20010231 A ID 20010231A ID 28213 A ID28213 A ID 28213A
Authority
ID
Indonesia
Prior art keywords
composition
reduce pain
transdermal method
transdermal
pain
Prior art date
Application number
IDW20010231A
Other languages
English (en)
Indonesian (id)
Inventor
Robert W Murdock
C Donald Williams
Original Assignee
Pharmaceuticals Applic Associa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/106,684 external-priority patent/US6290986B1/en
Application filed by Pharmaceuticals Applic Associa filed Critical Pharmaceuticals Applic Associa
Publication of ID28213A publication Critical patent/ID28213A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20010231A 1998-06-29 1999-06-29 Metode dan komposisi transdermal untuk meredakan rasa sakit ID28213A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,684 US6290986B1 (en) 1996-10-24 1998-06-29 Method and composition for transdermal administration of pharmacologic agents
US12290399P 1999-03-05 1999-03-05

Publications (1)

Publication Number Publication Date
ID28213A true ID28213A (id) 2001-05-10

Family

ID=26803907

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010231A ID28213A (id) 1998-06-29 1999-06-29 Metode dan komposisi transdermal untuk meredakan rasa sakit

Country Status (18)

Country Link
EP (1) EP1093348A4 (fr)
JP (1) JP2002519310A (fr)
KR (1) KR20010078754A (fr)
CN (1) CN1331576A (fr)
AU (1) AU4841599A (fr)
BG (1) BG105175A (fr)
BR (1) BR9912508A (fr)
CA (1) CA2335837A1 (fr)
HR (1) HRP20000905A2 (fr)
HU (1) HUP0102728A3 (fr)
ID (1) ID28213A (fr)
IL (1) IL140420A0 (fr)
MX (1) MXPA00012767A (fr)
NO (1) NO20006604L (fr)
PL (1) PL345216A1 (fr)
SK (1) SK20012000A3 (fr)
TR (1) TR200003801T2 (fr)
WO (1) WO2000000120A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
BR9809288A (pt) 1997-04-22 2001-08-07 Cocensys Inc Semicarbazonas e tiosemicarbazonas substituìdas carbocìclicas e heterocìclicas e utilização das mesmas
EP1500395B1 (fr) * 1999-07-01 2006-03-08 Pharmacia & Upjohn Company LLC Reboxétine pour traiter les fibromyalgies et d'autres troubles somatoformes
PT1632234E (pt) 1999-07-01 2007-07-09 Pharmacia & Upjohn Co Llc (s,s)-reboxetina para o tratamento da síndrome de fadiga crónica
WO2001041732A1 (fr) * 1999-12-06 2001-06-14 Gore Stanley L Compositions et procedes d'administration intranasale d'agents actifs destines au cerveau
IN191512B (fr) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP4865330B2 (ja) 2002-12-13 2012-02-01 デュレクト コーポレーション 経口ドラッグデリバリーシステム
JP2005154368A (ja) * 2003-11-27 2005-06-16 Teikoku Seiyaku Co Ltd ジソピラミド含有神経因性疼痛の鎮痛剤
JP4807721B2 (ja) * 2004-01-29 2011-11-02 株式会社 メドレックス 消炎鎮痛外用剤
AU2005287175B2 (en) 2004-09-17 2011-12-01 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP2007308403A (ja) * 2006-05-17 2007-11-29 Kenji Yoshida 皮膚外用剤
KR100880748B1 (ko) * 2006-08-29 2009-02-02 정헌택 디메톡시커큐민을 함유하는 혈관재협착 방지용 조성물
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP5826742B2 (ja) * 2009-05-07 2015-12-02 ドンコック ファーマシューティカル カンパニー リミテッド 神経損傷及び神経疾患の予防または治療用薬学組成物
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
JP2017505349A (ja) * 2014-02-11 2017-02-16 ドクター レディズ ラボラトリーズ リミテッド セレコキシブの非経口組成物
CA3117842A1 (fr) 2018-10-26 2020-04-30 Viramal Limited Composition de gel mucoadhesif
EP3659583B1 (fr) 2018-11-30 2023-06-07 Viramal Limited Procédé de préparation d'un agent coagulant, agent coagulant ainsi obtenu et utilisation de cet agent coagulant
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
FR3108841B1 (fr) * 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395420A (en) * 1981-12-09 1983-07-26 Bernstein Joel E Method and composition for treating pruritis
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain

Also Published As

Publication number Publication date
AU4841599A (en) 2000-01-17
WO2000000120A9 (fr) 2000-03-30
TR200003801T2 (tr) 2001-06-21
CN1331576A (zh) 2002-01-16
BR9912508A (pt) 2001-05-02
MXPA00012767A (es) 2002-08-09
NO20006604D0 (no) 2000-12-22
BG105175A (bg) 2001-11-30
HUP0102728A3 (en) 2002-12-28
CA2335837A1 (fr) 2000-01-06
HRP20000905A2 (en) 2001-08-31
IL140420A0 (en) 2002-02-10
WO2000000120A1 (fr) 2000-01-06
HUP0102728A2 (hu) 2002-03-28
JP2002519310A (ja) 2002-07-02
PL345216A1 (en) 2001-12-03
EP1093348A4 (fr) 2003-07-16
EP1093348A1 (fr) 2001-04-25
KR20010078754A (ko) 2001-08-21
SK20012000A3 (sk) 2001-08-06
NO20006604L (no) 2001-02-28

Similar Documents

Publication Publication Date Title
ID28213A (id) Metode dan komposisi transdermal untuk meredakan rasa sakit
ID29298A (id) Metode dan komposisi untuk mengobati apnea selama tidur
ID28728A (id) Komposisi dan proses pengkrepan
ID26964A (id) Komposisi dan metode untuk pengaturan pengaktifan limfosit
ID17007A (id) Film susunan penghalang dan metode untuk menghasilkannya
IL139533A0 (en) Improvements in or relating to building elements and methods in relation to same
ID25427A (id) Proses-proses dan zat-zat antara untuk membuat senyawa-senyawa anti-kanker
ID25651A (id) Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait
ID20996A (id) Lembaran penyeka dan metode untuk memproduksinya
EE03966B1 (et) Valuvaigistava toimega ühendid ja nende valmistamise meetod
ID26161A (id) Serat poliester dan metode untuk membuatnya
ID30037A (id) Metoda untuk mereduksi tingkat serum trigliserida dan untuk menghambat angiogenesis menggunakan asam-asam indolalkanoat tersubstitusi
ID17437A (id) Metoda dan komposisi untuk membuat kulit terang
DE69721286D1 (de) Befestigungsvorrichtung sowie anwendungsverfahren dafür
AR026046A1 (es) NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA
GB9814619D0 (en) Materials and methods relating to encapsulation
DE69700884D1 (de) In flüssiger Form zu applizierende, wasserabweisende Zusammensetzung
FI970369A (fi) Menetelmä interferenssin vähentämiseksi ja radiojärjestelmä
FI103463B1 (fi) Tietokone ja menetelmä tietokoneen käyttämiseksi
ID30044A (id) Metode dan komposisi untuk meminimkan pengotor biologi dan koloid
ID30135A (id) Komposisi-komposisi dan metode-metode untuk mengontrol serangga-serangga
ID20819A (id) Semaforin l manusia (h-sema l) dan semaforin yang sesuai dalam spesies lainnya
ID26704A (id) Pemercepat bmp-4 manusia dan metode untuk menyelidiki substansi yang berhubungan dengan tulang dengan menggunakan hal yang sama
IS4628A (is) Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
DE59912433D1 (de) Vorverzerrung zur verringerung von intersymbolinterferenz sowie mehrfachzugriffsinterferenz